HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer. [electronic resource]
Producer: 20140415Description: 43-53 p. digitalISSN:- 1573-7217
- Antibodies, Monoclonal -- immunology
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents -- pharmacology
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- classification
- Cell Line, Tumor
- Cohort Studies
- Decision Trees
- Disease-Free Survival
- Drug Resistance, Neoplasm
- Female
- Fluorescent Antibody Technique, Indirect
- Gene Expression Regulation, Neoplastic
- Genes, erbB-2
- Humans
- Kaplan-Meier Estimate
- Neoplasm Proteins -- biosynthesis
- Peptide Fragments -- analysis
- Prognosis
- Protein Structure, Tertiary
- Receptor, ErbB-2 -- analysis
- Receptor, ErbB-3 -- analysis
- Retrospective Studies
- Single-Blind Method
- Trastuzumab
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study
There are no comments on this title.
Log in to your account to post a comment.